Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation

Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medic

Related Keywords

New York ,United States ,Algiers ,Alger ,Algeria ,France ,Paris ,France General ,East Harlem ,American ,Miriam Merad ,Denniss Charney ,Jennifer Lipschultz Precision Immunology Institute ,Merck Co ,Mount Sinai Health System ,Astrazeneca ,National Academy Of Medicine ,Dean For Translational Research ,National Academy Of Science ,University Of Algiers ,University Of Paris ,National Institutes Of Health ,Mount Sinai Human Immune Monitoring Center ,Health System ,Department Of Immunology ,Novo Nordisk ,Precision Immunology Institute ,Association Of American Medical Colleges ,Stanford University ,Icahn School Of Medicine At Mount Sinai ,American Association For Cancer Research ,Human Immune Monitoring Center ,Academy Of Immuno ,Translational Research ,Therapeutic Innovation ,Icahn School ,Icahn Mount Sinai ,Mount Sinai Professor ,Cancer Immunology ,Human Immune Monitoring ,Mount Sinai ,Joel Ehrenkranz Dean ,Academic Affairs ,Mount Sinai Health ,National Academy ,American Association ,Cancer Research ,National Institutes ,American Medical Colleges ,Mount Sinai Innovation Partners ,New York City ,Upper East Side ,Newswise ,Esearch And Innovation Therapeutic Cell Tissue Immunologist ,Embargoed Feed Hidden ,